Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ACS Bio and Med Chem Au is Scopus-indexed (Q1, CiteScore 7.5), WoS ESCI, DOAJ. Published by American Chemical Society.
Checked against the index lists dated .
ISSN 2694-2437Verify ISSN ↗
Publisher: American Chemical Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 42 / 191 | 78th | Q1 |
| Biochemistry | 106 / 448 | 76th | Q1 |
| Drug Discovery | 42 / 161 | 74th | Q2 |
| Molecular Biology | 123 / 414 | 70th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 7.5.
ACS Bio and Med Chem Au is Q1 in Pharmaceutical Science (rank 42 of 191), Q1 in Biochemistry (rank 106 of 448) and Q2 in Drug Discovery (rank 42 of 161), by CiteScore 2025. It is ranked in 4 subject areas in all.
ACS Bio and Med Chem Au is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.5, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.267, quartile Q1, with an H-index of 21.
The publisher lists an article processing charge of about US$3,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ACS Bio and Med Chem Au is published by American Chemical Society. Its ISSN is 2694-2437.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
ACS Bio and Med Chem Au has an h-index of 27 and a 2-year mean of 2.93 citations per paper (OpenAlex). Its Scopus CiteScore is 7.5, quartile Q1. On 2-year citations it ranks #64 of 177 Scopus journals in Pharmaceutical Science.
ACS Bio and Med Chem Au published 83 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from United States (36.5%), Germany (6.5%) and Japan (5.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.